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Abstract. 
 
Type IV collagen in 
 
Caenorhabditis elegans
 
 
is produced by two essential genes, 
 
emb-9
 
 and 
 
let-2
 
, 
 
which encode 
 
a
 
1- and 
 
a
 
2-like chains, respectively. The 
distribution of EMB-9 and LET-2 chains has been char-
acterized using chain-specific antisera. The chains colo-
calize, suggesting that they may function in a single het-
erotrimeric collagen molecule. Type IV collagen is 
detected in all basement membranes except those on 
the pseudocoelomic face of body wall muscle and on 
the regions of the hypodermis between body wall mus-
cle quadrants, indicating that there are major structural 
differences between some basement membranes in 
 
C. 
elegans.
 
 Using lacZ/green fluorescent protein (GFP) re-
porter constructs, both type IV collagen genes were 
shown to be expressed in the same cells, primarily body 
wall muscles, and some somatic cells of the gonad. Al-
though the pharynx and intestine are covered with 
basement membranes that contain type IV collagen, 
these tissues do not express either type IV collagen 
gene. Using an epitope-tagged 
 
emb-9
 
 construct, we 
show that type IV collagen made in body wall muscle 
cells can assemble into the pharyngeal, intestinal, and 
gonadal basement membranes. Additionally, we show 
that expression of functional type IV collagen only in 
body wall muscle cells is sufficient for 
 
C. elegans
 
 to 
complete development and be partially fertile. Since 
type IV collagen secreted from muscle cells only assem-
bles into some of the basement membranes that it has 
access to, there must be a mechanism regulating its as-
sembly. We propose that interaction with a cell sur-
face–associated molecule(s) is required to facilitate 
type IV collagen assembly.
 
B
 
asement 
 
membranes are thin sheets of specialized
extracellular matrix that underlie or surround
groups of cells, separating them from other cells
and/or adjacent connective tissue. The major constituents
of basement membranes are type IV collagen, laminin, ni-
dogen (entactin), and heparan sulfate proteoglycan (perle-
can) (59, 72). The functions and interactions of these mol-
ecules have primarily been studied in vertebrates using in
vitro systems. These proteins, and presumably their func-
tions, have been conserved throughout metazoan evolu-
tion. We are analyzing type IV collagen in vivo in the nem-
atode 
 
Caenorhabditis elegans
 
 (26, 27) to further understand
the assembly and functions of this basement membrane
molecule.
The structure of type IV collagen has been conserved
from nematodes to mammals (27, 29). The majority of the
molecule is the central Gly-X-Y repeat domain, which folds
into a triple-helical structure. There are 
 
z
 
20 sites at which
the triple-helical structure is interrupted by amino acids in
which glycine is not at every third position. At the amino
terminus, there is a short non-(Gly-X-Y) domain contain-
ing four conserved cysteines, and at the carboxyl terminus,
there is the globular NC1 domain that contains 12 con-
served cysteines. In basement membranes, type IV col-
lagen molecules form a complex polygonal network stabi-
lized by intermolecular disulfide bonding (59). NC1 domains
associate to form dimers, while amino terminal (7S) do-
mains associate into tetramers. Lateral associations be-
tween type IV molecules are also involved in forming the
network seen in basement membranes (70, 71).
Six type IV collagen genes have been identified in mam-
mals, 
 
a
 
1–
 
a
 
6 (22, 29). The predominant form of type IV
collagen in mammals is a heterotrimer of two 
 
a
 
1 and one
 
a
 
2(IV) chains. There are two genes that encode type IV
collagen chains in 
 
C. elegans
 
, 
 
emb-9
 
 and 
 
let-2
 
 (19, 20, 50).
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EMB-9 is an 
 
a
 
1(IV)-like chain and LET-2 is an 
 
a
 
2(IV)-
like chain. The six mammalian genes are organized as
closely spaced pairs of one 
 
a
 
1-like and one 
 
a
 
2-like gene in
head-to-head orientation (22, 29). In contrast, the 
 
C. ele-
gans
 
 type IV collagen genes are located on different chro-
mosomes. Two type IV collagen genes have been identi-
fied in sea urchin (9, 10), and one each in 
 
Drosophila
 
 (3,
4), and the parasitic nematodes 
 
Brugia
 
 (7) and 
 
Ascaris
 
(46). There is no evidence for more than two type IV col-
lagen genes in any invertebrate.
The diversity of type IV collagen is increased in 
 
C. ele-
gans
 
 by alternative splicing of the 
 
a
 
2(IV) chain gene 
 
let-2
 
(50). One splice variant is predominant in embryos, while
the other is predominant in larvae and adults. The alterna-
tive splicing does not change the length of the molecule
but changes a small number of amino acids in the Gly-X-Y
repeat domain. The same alternative splicing occurs in the
 
a
 
2(IV) chain of 
 
Ascaris
 
 (47). The importance of these splice
variants is unknown, but they may increase the complexity
of type IV collagen functions.
The predominant form of type IV collagen in mammals,
(
 
a
 
1)
 
2
 
a
 
2, is abundant in most basement membranes (22, 24,
48). The four additional mammalian chains, 
 
a
 
3–
 
a
 
6(IV),
have more restricted tissue distributions, being most abun-
dant in the kidney (37, 43, 45, 68). Mutations in the human
 
a
 
3, 
 
a
 
4, and 
 
a
 
5(IV) collagen genes can cause Alport syn-
drome, a progressive glomerulonephritis variably associ-
ated with hearing loss and ocular lesions (2, 31, 41, 60). A
similar nephrotic syndrome is seen in dogs with mutations
in the 
 
a
 
5(IV) collagen gene (73) and in mice with a knock-
out of the 
 
a
 
3(IV) collagen gene (8, 38). The primarily re-
nal focus seen in Alport syndrome is consistent with the
localization of the 
 
a
 
3–
 
a
 
5(IV) chains primarily in kidney.
Mutations have not been identified in the mammalian 
 
a
 
1
or 
 
a
 
2(IV) collagen genes.
Mutations have been characterized in the 
 
C. elegans
 
 
 
a
 
1
and 
 
a
 
2(IV) collagen genes, 
 
emb-9
 
 and 
 
let-2
 
 (20, 20a, 51).
Mutations in either of the two genes cause similar defects.
Most of the mutations are substitutions for glycines in the
Gly-X-Y repeat domain and cause temperature-sensitive
phenotypes. At nonpermissive temperature (25
 
8
 
C), most
of these mutations cause arrest at the twofold stage of em-
bryonic development. At intermediate temperature (20
 
8
 
C),
they generally cause larval arrest or adult sterility. At the
permissive temperature (15
 
8
 
C), most of the mutations allow
animals to develop and reproduce. Thus, normal EMB-9
and LET-2 are required for both viability and fertility. The
evidence that 
 
emb-9
 
 and 
 
let-2
 
 are the only type IV collagen
genes in 
 
C. elegans
 
 and their embryonic lethal phenotypes
suggest that their products may be widely distributed,
analogously to the mammalian 
 
a
 
1 and 
 
a
 
2 chains.
Here we show that the EMB-9 and LET-2 type IV col-
lagen chains are colocalized and are found in most, but not
all, basement membranes in 
 
C. elegans.
 
 We show that the
 
emb-9
 
 and 
 
let-2
 
 genes are expressed in mesoderm, primar-
ily body wall muscle and somatic gonadal cells. We dem-
onstrate that EMB-9 produced in body wall muscles can
assemble into the basement membranes that surround
other tissues and that body wall muscle expression is suffi-
cient for 
 
C. elegans
 
 development. Our results indicate that
a mechanism must exist to control the sites of assembly of
type IV collagen in basement membranes.
 
Materials and Methods
 
C. elegans Strains
 
Animals were maintained as described by Brenner (6). The 
 
C. elegans
 
 va-
riety Bristol isolate N2 is designated as wild-type. The mutant strain used
in this study, 
 
unc-36(e251) emb-9(g23cg45)/qC1
 
[unc-36(
 
1
 
)emb-9(
 
1
 
)], was
generated by reverting the temperature-sensitive dominant lethality of
 
emb-9(g23)
 
 (20a). The 
 
cg45
 
 mutation converts Gln1388 of EMB-9 to a ter-
mination codon.
 
Preparation of Type IV Collagen Antisera
 
cDNA fragments encoding the entire NC1 domains of EMB-9 and LET-2
were generated by reverse transcriptase–PCR amplification and cloned
into pGEX fusion protein vectors (Pharmacia LKB Biotechnology, Inc.,
Piscataway, NJ). Fusion proteins were isolated in inclusion bodies after
overexpression in 
 
Escherichia coli.
 
 The inclusion bodies were solubilized
in SDS/
 
b
 
-mercaptoethanol sample buffer (30) and electrophoresed on
SDS–polyacrylamide gels, and the fusion protein bands were excised from
the gels and used to immunize rabbits. Synthetic peptides derived from
the NC1 domain of EMB-9 (CVDQDKQFRKPMSQ) or from exon 9 of
LET-2 (CREFTGSGSIVGPR) were coupled to BSA using 
 
m
 
-maleinido-
benzoyl-
 
N
 
-hydroxysuccinimide ester (21).
Rabbit antisera against fusion protein and peptide antigens were gener-
ated commercially (Hazelton Research Products, Inc., Denver, PA). Sera
against synthetic peptides were affinity purified using Actigel (Serogene
Bioseparations, Arcadia, CA) columns coupled with the same peptide.
Fusion protein antisera were first affinity purified on columns coupled
with the fusion protein to which they were generated. Cross-reacting anti-
bodies were then removed by passing the affinity-purified anti–EMB-9
sera over a column containing the LET-2 fusion protein, and vice versa.
Purified antisera were stored at 
 
2
 
20
 
8
 
C in PBS with 50% glycerol, 1% BSA.
 
Western Blots
 
C. elegans
 
 extracts were prepared by washing mixed-stage populations ex-
tensively with large volumes of distilled water (dH
 
2
 
O).
 
1
 
 After pelleting,
they were mixed immediately in an equal volume of 2
 
3
 
 Laemmli sample
buffer (30), containing 5% freshly added 
 
b
 
-mercaptoethanol, and boiled
for 10 min. Extracts were then incubated for 12–24 h at room temperature,
boiled 10 min, and stored at 
 
2
 
20
 
8
 
C.
Western blots were performed by standard procedures (21). 
 
C. elegans
 
protein extracts were electrophoresed on either 7.5 or 4% polyacrylamide
gels and transferred to nitrocellulose using 25 mM Tris, 192 mM glycine,
0.1% SDS, 10% methanol. Nitrocellulose filters were stained with Pon-
ceau S to determine the position of molecular mass markers and then
blocked for at least 1 h in BB (BB: 10% dry milk, 0.3% Tween 20 in PBS).
Filters were incubated with anti–type IV collagen antibodies diluted
1:500–1:1,000 in BB for 1 h at room temperature and washed with 0.3%
Tween 20 in PBS. They were then incubated with alkaline phosphatase–
conjugated goat anti–rabbit antibodies (Sigma Chemical Co., St. Louis,
MO) diluted 1:1,000 in BB, washed, and developed with BCIP/NPT (21).
For competition experiments, anti–type IV collagen antibodies were
preincubated for 1 h at room temperature with 200–400 
 
m
 
g/ml of the fu-
sion protein or 100 
 
m
 
g/ml of the peptide used as the original antigen. The
antibody/antigen mixture was then used to stain blots as described above,
or to stain animals as described below.
 
Antibody Staining of C. elegans
 
Animals were prepared for immunofluorescence analysis by one of three
methods. In the first, eggs were collected from alkaline hypochlorite–
treated animals (55), rinsed twice with dH
 
2
 
O, fixed with 3% paraformal-
dehyde in PBS for 15 min at room temperature, rinsed twice with dH
 
2
 
O,
and stored at 
 
2
 
80
 
8
 
C in 100% methanol for 30 min to 7 d. Alternatively,
animals in dH
 
2
 
O were pipetted onto slides subbed with 0.2% gelatin,
0.1% polylysine, 0.01% chrome alum, covered with a coverslip, and frozen
on dry ice. The coverslip was cracked off with a razor blade, and the slide
was immersed in 
 
2
 
20
 
8
 
C methanol for 5 min, followed by 
 
2
 
20
 
8
 
C acetone
for 3 min, and air dried. Lastly, larvae and adults were prepared as de-
scribed by Finney and Ruvkun (11).
 
1. 
 
Abbreviations used in this paper
 
: dH
 
2
 
O, distilled water; GFP, green flu-
orescent protein; HA, hemagglutinin; NDS, normal donkey serum. 
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After fixation, animals were rehydrated and either blocked immedi-
ately for 1 h in PBS containing 0.1% Triton X-100 (PBS-T) and 10% nor-
mal donkey serum (NDS), or treated with 6 M urea, 0.1 M glycine, pH 3.5,
for 15 min (69) and rinsed 3
 
3
 
 with PBS before blocking. Samples were
incubated with antibodies against type IV collagen (EMB-9 or LET-2),
myosin heavy chain B (UNC-54), or mouse anti-hemagglutinin (HA)
monoclonal antibody (Boehringer-Mannheim Corp., Indianapolis, IN) in
PBS-T–NDS overnight at 4
 
8
 
C for 1 h at 37
 
8
 
C, washed with PBS-T, incu-
bated 1 h at 37
 
8
 
C with FITC donkey anti–rabbit and LRSC donkey anti–
mouse secondary antibodies (Jackson ImmunoResearch, West Grove,
PA) in PBS-T–NDS, washed with PBS-T containing 1 
 
m
 
g/ml diamidi-
nophenolindole, followed by PBS alone.
To prepare frozen sections, animals were fixed with 3% paraformalde-
hyde in 0.1 M sodium phosphate buffer, pH 7.0, for 20 min at room tem-
perature. After washing in water, they were resuspended in 30% sucrose
in PBS at 4
 
8
 
C. After the animals sank to the bottom of the tube, the over-
lying sucrose solution was removed and an equal volume of OCT com-
pound (Miles, Inc., Elkhart, IN) was added. Frozen sections were col-
lected on polylysine-coated slides and dried for 30 min before being
blocked and stained as described above.
 
Construction and Analysis of Type IV Collagen 
Expression Reporters
 
Reporter constructs for 
 
emb-9
 
 were generated from the plasmid pJJ359,
which contains the complete 
 
emb-9
 
 gene flanked by 4.3 kb of 5
 
9
 
 upstream
and 0.5 kb of 3
 
9
 
 sequence (Fig. 1 
 
A
 
). pJJ359 is capable of transgenic rescue
of 
 
emb-9
 
 mutant animals. To generate the 
 
emb-9:lacZ
 
 reporter construct
pJJ444, the 10-kb XmaI-SaII fragment from pJJ359 was inserted into
XmaI-XhoI cut pPD34.110. PPD34.110 contains the 
 
E. coli
 
 lacZ gene with a
membrane stop transfer sequence and 3
 
9
 
 untranslated sequences from
 
unc-54
 
 (13.). An 
 
emb-9:
 
green fluorescent protein (GFP) reporter, pJJ446,
was made by removing the lacZ region of pJJ444 by KpnI-SpeI digestion
and inserting the KpnI-SpeI GFP-containing fragment from pPD95.75
(provided by A. Fire, S. Xu, J. Ahnn, and G. Seydoux).
Another emb-9:lacZ reporter construct, pJJ318, was made by inserting
a HindIII-PvuI (21672 to 218 relative to emb-9 start codon) fragment
from the lambda phage clone CH'2 into HindIII-SmaI–digested pPD21.28.
CH'2 contains the complete emb-9 gene and is capable of transgenic res-
cue of emb-9 mutant animals (20). pPD21.28 contains the E. coli lacZ
gene with a nuclear localization signal and 39 untranslated sequences from
unc-54 (13).
Two let-2 reporter constructs were generated from the plasmid pJJ353,
which contains the complete let-2 gene with 2.2 kb of 59 upstream and 430 bp
of 39 untranslated sequence (Fig. 1 B). pJJ353 is capable of transgenic res-
cue of let-2 mutant animals (50). pJJ360 was made by ligating the 6-kb SphI-
EcoRV fragment from pJJ353 into SphI-SmaI–digested pPD34.110. pJJ361
was made by ligating the 4-kb SmaI-ApaI fragment from pPD34.110 with
the 11-kb EcoRV-ApaI fragment from pJJ353. pPD34.110 contains the E.
coli lacZ gene with a membrane stop transfer sequence and 39 untrans-
lated sequences from unc-54 (13). An additional let-2 reporter, pJJ325,
was generated by cloning the 3.2-kb AvaI fragment from cosmid C12F7
(23.2 to 120 kb relative to let-2 initiation codon) into SmaI-digested
pPD22.04 (13).
DNAs were injected into hermaphrodite gonads as described (36) us-
ing pRF4[rol-6(su1006)] (28) as a transformation marker. The emb-9 re-
porter construct pJJ318 was integrated into the genome by g-irradiation
and selection of a line that segregates 100% roller progeny. b-galactosi-
dase activity was visualized by staining as described (12), after fixation for
15 min with 3% paraformaldehyde in PBS and washing with PBS.
Construction and Analysis of Epitope-tagged Type
IV Collagen
The pJJ400 construct was made by cloning the 3.6-kb HindIII-XbaI frag-
ment from pJJ359 (Fig. 1 A) into the pCRII vector (InVitrogen, San Di-
ego, CA), which is useful because it has no AatII sites. PCR was per-
formed on first strand cDNA derived from mixed-stage C. elegans RNA
using primers emb9ectA (244 to 29, relative to translation start) and
emb9ectB2 (13268 to 13250). Emb9ectA has a single nucleotide change,
T-38G, relative to wild-type to create a HindIII site. Emb9ectB2 has a
synthetic HindIII site appended. PCR products were HindIII digested and
Figure 1. Diagrams of emb-9 and let-2 expres-
sion constructs. Constructs involving emb-9
were derived from the genomic clone pJJ359
(A). Constructs involving let-2 were derived
from the genomic clone pJJ353, or cosmid
C12F7 (B). Exons are indicated as open
boxes, introns as thick lines, and flanking se-
quences as thin lines. The unc-54 promoter/
enhancer is stippled, and the HA epitope tag
and reporter sequences are solid. The emb-9
and let-2 genomic sequences are drawn to
scale, but exogenous sequences are not.The Journal of Cell Biology, Volume 137, 1997 1174
cloned into HindIII-digested pJJ400 to generate pJJ401. The 1.6-kb AatII
fragment was removed from pJJ401 and replaced with the 1.6-kb AatII
fragment from pJJ359 to generate pJJ402. PCR was performed on first
strand cDNA derived from mixed-stage C. elegans RNA using primers
emb9ectD (15725 to 15750) and embtwoHA, which is the complement of
17217 to 17231 with two HA epitope tags (67), a termination codon, and
an Xba site appended. PCR products were SaII-XbaI digested and cloned
into SaII-XbaI–digested pJJ402 to generate pJJ404. The insert in pJJ404
was isolated after NsiI-ApaI digestion and ligated into NheI-KpnI–digested
pPD30.38, after both fragments had been blunt ended with T4 DNA poly-
merase. pPD30.38 contains the unc-54 body wall muscle myosin promoter
and enhancer (35). The resulting clone, pJJ414 (Fig. 1 A), has the unc-54
promoter and enhancer, the emb-9 gene with introns 1–6, 10, and 11 re-
moved and two copies of HA inserted immediately preceding the termina-
tion codon, and 39 untranslated sequences from pPD30.38.
Transgenic Rescue of emb-9(null) by Expression in 
Muscle Cells
Plasmid pJJ427 was constructed by ligating the 3.5-kb ApaI-KpnI frag-
ment from pPD30.38 with the 7.8-kb PvuI-PstI fragment from pJJ359 after
blunt ending. This construct has the wild-type emb-9 gene (215 to 17750)
under control of the unc-54 promoter and enhancer. pJJ427 was used to
generate transgenic strains in unc-36(e251) emb-9(g23cg45)/qC1 animals.
The constructs pJJ445 and pJJ429 were generated by ligating the emb-9
gene and reporter containing NsiI-SpeI fragments from pJJ444 or pJJ446
with the unc-54 promoter containing NsiI-XbaI fragment from pJJ427.
Results
Characterization of Anti–type IV Collagen Antisera
We have used four antisera to examine the distribution of
type IV collagen chains in C. elegans. Two antisera were
generated against fusion proteins containing the NC1 do-
mains of EMB-9 (NW155) or LET-2 (NW153), one against
a peptide from the NC1 domain of EMB-9 (NW1910), and
one against a peptide derived from an interruption of the
Gly-X-Y domain of LET-2 (NW68). Each of the sera was
affinity purified using the original antigen. In addition, the
fusion protein sera were cross adsorbed on columns carry-
ing the fusion protein from the other type IV collagen chain.
The purified anti–EMB-9 antisera do not cross-react with
the LET-2 fusion protein, and the purified anti–LET-2 an-
tisera do not cross-react with the EMB-9 fusion protein
(data not shown).
On Western blots of total C. elegans extracts, both
EMB-9 antisera react with a major band of z240 kD, and
both LET-2 antisera react with a major band of z210 kD
(Fig. 2). The predicted molecular masses of EMB-9 and
LET-2, after cleavage of signal peptides, are 168 and 165 kD,
respectively. Their higher apparent molecular masses are
at least partly due to the abnormally slow migration of col-
lagens relative to globular protein molecular mass stan-
dards on SDS–polyacrylamide gels (17). The apparent mo-
lecular masses of the reacting bands differ depending on
the percentage acrylamide in the gels, another characteris-
tic of collagens. The fact that the EMB-9 and LET-2 anti-
sera specifically react with proteins of different mobilities
indicates that they are specific for the chains against which
they were made. Activity on Western blots is eliminated
by competition with the original antigen, but not by com-
petition with antigen from the other type IV collagen chain
(Fig. 2 B). Similar results were obtained in competition ex-
periments on embryos prepared for immunofluorescence.
The specificity of the antisera is further supported by the
fact that the anti–EMB-9 antisera do not react with em-
bryos homozygous for either a stop codon or an internal
deletion of emb-9 (20a).
Distribution of Type IV Collagen
Ultrastructural analyses of C. elegans (1, 64–66) have iden-
tified basement membranes on the pseudocoelomic face of
the hypodermis and surrounding the body wall muscles,
pharynx, intestine, and gonad (Fig. 3). We have deter-
mined the distributions of the a1 and a2(IV) collagen chains
EMB-9 and LET-2 in whole mount animals using specific
anti–type IV collagen antisera. All four antisera generate
essentially identical immunofluorescence patterns, so be-
low we refer to type IV collagen localization rather than
to the separate chains. The colocalization of EMB-9 and
LET-2 chains further supports the specificity of the anti-
sera and suggests that EMB-9 and LET-2 may assemble
into the same heterotrimeric collagen molecule.
At 208C, C. elegans embryogenesis takes z800 min from
first division to hatching (55). Most cell divisions are com-
pleted during the first 350 min, after which the embryo be-
gins elongation from an ovoid ball into a tube approxi-
mately four times the length of the egg. We refer to the
stages of morphogenesis, from the start of elongation to
hatching, by the length of the embryo relative to the egg
shell, progressively as lima, comma, 1 1/2-fold, twofold,
threefold, and fourfold.
Type IV collagen is first detectable in body wall muscle
Figure 2. Antibodies against the a1 and a2(IV) collagen chains,
EMB-9 and LET-2, react specifically to their respective antigens.
Western blots of C. elegans extract were probed with type IV col-
lagen antisera. (A) Strips cut from a blot of C. elegans extract
were reacted with the anti–EMB-9 peptide antiserum 1910 (lane
1) or the anti–LET-2 peptide antiserum 68 (lane 2). (B) C. ele-
gans extract was reacted with fusion protein–generated antiserum
NW153 against LET-2 (lanes 1–3) or antiserum NW155 against
EMB-9 (lanes 4–6). Before reacting with the blot, the antibodies
were incubated with no competitor (lanes 1 and 4), LET-2 fusion
protein (lanes 2 and 5), or EMB-9 fusion protein (lanes 3 and 6).
Antibodies incubated with the antigen to which they were made
no longer react to the worm extract (lanes 2 and 6), while those
incubated with the other fusion protein still react to the appropri-
ate size band (lanes 3 and 5).Graham et al. Type IV Collagen Distribution in Caenorhabditis elegans 1175
cells at the onset of morphogenesis, just preceding the lima
stage (data not shown). At this early stage, the type IV col-
lagen stain appears to be completely intracellular. By the
1 1/2-fold stage, strong type IV collagen stain is seen in
body wall muscle cells and at the interface between them
and the hypodermis (Fig. 4, A and B). Weak stain is seen
surrounding the pharyngeal and intestinal primordia be-
ginning at the comma stage, and this stain becomes intense
by the 1 3/4-fold stage (Fig. 4, C and D). Intracellular stain
is also seen in the head mesodermal cell and its lineal ho-
mologue MS.pppaaa by this stage (Fig. 4, E and F).
From about the comma stage on, stain for type IV col-
lagen accumulates in four stripes at the interfaces between
the hypodermis and the four body wall muscle quadrants
(Fig. 4, G–J). There is no stain detectable in the hypoder-
mal basement membrane that is located between the mus-
cle quadrants. There is also no detectable stain on the
pseudocoelomic face of body wall muscle cells. This same
staining pattern is seen with all four type IV antisera and is
not altered after treatment with acid urea to unmask po-
tentially hidden epitopes (69).
After the twofold stage, six cells in the nerve ring fre-
quently exhibit stain for type IV collagen (Fig. 4 K). Based
on their positions, these cells appear to be the GLR cells,
which are considered to have glial-like characteristics (66).
The GLR cells have broad thin processes that separate the
muscle arms that project under the nerve ring from the
pharynx. At the time of hatching, strong type IV collagen
stain is seen at the interface between the body wall muscle
cells and the hypodermis and surrounding the pharynx, in-
testine, and primordial gonad (Fig. 4 L).
In larval and adult animals, the distribution of type IV
collagen generally remains the same as that seen in late
embryos; underlying the body wall muscles and surround-
ing the pharynx, intestine, and gonad (Fig. 5 C). As in em-
bryos, type IV collagen is not detectable in the hypodermal
basement membranes between body wall muscle quad-
rants or on the pseudocoelomic face of body wall muscles
(Fig. 5, A and B). In larvae and adults, coelomocytes can
be seen to stain with the type IV antisera (Fig. 5 D). The
basement membrane surrounding the gonad stains for
type IV collagen throughout larval development and in
adults. However, in many L4 and adult animals the go-
nadal stain is not uniform, being more intense around the
spermatheca (Fig. 5 E) and around the distal ends of the
gonad arms. Although the basement membranes sur-
rounding the pharynx and intestine stain with the type IV
antisera, intracellular stain in these tissues was never seen
in embryos, larvae, or adults. A schematic summary of the
observed type IV collagen staining pattern is shown in Fig. 3.
Type IV Collagen Gene Expression
The sites of emb-9 and let-2 expression have been deter-
mined using lacZ and GFP reporter constructs in trans-
genic animals. For both genes, the reporter constructs
were derived from clones that are capable of rescuing mu-
tant animals when present in transgenic arrays. For emb-9,
constructs in which lacZ or GFP are inserted into exon 10
and that have 4.3 kb of 59 upstream sequences, pJJ444/446
(Fig. 1 A), show strong activity in the cells that exhibit in-
tracellular stain with anti–EMB-9 antisera. A construct
with 1.7 kb of 59 upstream sequences in a transcriptional
fusion with lacZ, pJJ318, has also been analyzed, both as
an extrachromosomal array and integrated into the ge-
nome. This construct has an expression pattern very simi-
lar to pJJ444 but often shows activity in two to four of the
most posterior intestinal cells in early larvae and has lower
activity in body wall muscles of late larvae and adults.
For let-2, 3.2 kb of 59 upstream sequences, which is more
than is required for transgenic rescue of mutant animals,
shows very little activity when used in a transcriptional fu-
sion with lacZ, pJJ325 (Fig. 1 B). However, insertion of
lacZ into exon 13 of let-2 generates a translational fusion,
pJJ360, that shows strong activity in the same cells that stain
intracellularly with type IV collagen antisera. The pres-
ence of further 39 exons and flanking sequences, pJJ361,
have no effect on the observed expression pattern. The let-2
Figure 3. Schematic cross
sections of C. elegans
through the head (left) and
midbody (right) showing the
locations of basement mem-
branes. Basement mem-
branes that stain with anti–
EMB-9 and anti–LET-2 anti-
sera are shown as thick black
lines; those that do not stain
are shown as thick stippled
lines. Tissues that express the
emb-9 and let-2 genes are in-
dicated with white text on a
black background; those that
do not are shown as black
text on a white background.
Note that only a subset of so-
matic gonadal cells express
emb-9 and let-2.The Journal of Cell Biology, Volume 137, 1997 1176
expression reporters, pJJ360/361, show the same spatial
and temporal expression patterns as the emb-9 pJJ444/446
reporter constructs.
Weak b-galactosidase and GFP activity can first be de-
tected in body wall muscle cells of lima stage embryos (data
not shown). In embryos of all later stages, b-galactosidase
and GFP activity is strong in body wall muscle cells (Fig.
6, A and B), and no activity is seen in pharyngeal, intesti-
nal, or hypodermal cells. In situ hybridization of C. elegans
embryos with a probe derived from emb-9 also shows lo-
calization in the body wall muscles (56). In L1 larvae (Fig.
6 D), body wall muscle cells continue to show activity, and
activity is also seen in the ring ganglion (presumptive GLR
cells), head mesodermal cell, coelomocytes, and intestinal
and anal muscles. Beginning at the L2 larval stage, the dis-
tal tip cells of the developing gonad show strong activity
(Fig. 6 C). In L3–L4 animals, the level of activity in the dis-
tal tip cells often appears to be greater than that seen in
the body wall muscles (Fig. 6 E). In L4 animals, spermathe-
cal cells begin to show b-galactosidase activity, and this ac-
tivity can still be seen in adults (Fig. 6 F). In adult animals,
type IV collagen reporter activity is seen in vulval and
uterine muscles (Fig. 6 F), body wall muscles (Fig. 6 G), as
well as distal tip cells (Fig. 6 H).
The  emb-9 and let-2 reporters showed activity in the
same cells that stained with the anti–EMB-9 and –LET-2
antisera, with the exception of some accessory muscles.
Although the intestinal, anal, vulval, and uterine muscles
showed activity with type IV expression reporters, intra-
cellular staining of these cells with anti–type IV collagen
antisera was not apparent. It is possible that antibody
staining of these cells was weak and/or obscured by the in-
Figure 4. Type IV collagen distribution in wild-type C. elegans embryos. Embryos were stained with anti–LET-2 antiserum 68 (A, E, G,
and K) or anti–EMB-9 antiserum 1910 (C, I, and L). The same staining patterns are seen with all anti–EMB-9 and anti–LET-2 antisera.
The same embryos were stained with anti–UNC-54 myosin monoclonal antibody to identify body wall muscle cells (B, D, F, H, and J).
(A) A 1 1/2-fold embryo shows type IV collagen accumulation in body wall muscle cells. (B) Anti–UNC-54 staining of the same embryo
in A. (C) A 1 3/4-fold embryo shows type IV collagen in body wall muscle cells and covering the pharynx primordium (p). (D) Anti–
UNC-54 staining of the same embryo in C. (E) A 1 1/2-fold embryo showing type IV collagen in body wall muscle cells, and the head
mesodermal cell (hmc) and its lineal homologue. (F) Anti–UNC-54 staining of the same embryo in E. Note that the hmc and its homo-
logue do not stain for UNC-54. (G) A twofold embryo showing type IV collagen staining under the body wall muscle quadrants (two of
the four are indicated with arrowheads), but not between them. Stain around the pharynx (p) appears as a ring in the head in this optical
cross-section. Stain around the intestine (i) is seen in the posterior of the embryo. (H) Anti–UNC-54 staining of the same embryo in G.
(I) Surface focal plane of a threefold embryo shows type IV collagen as a stripe overlying a body wall muscle quadrant. (J) Anti–UNC-
54 staining of the same embryo in I. (K) Type IV collagen staining of two ring ganglion cells (rg), believed to be GLR cells, in a fourfold
embryo. The posterior bulb of the pharynx (p) is indicated. (L) An embryo at hatching showing type IV collagen stain of basement
membranes covering the pharynx (p), intestine (i), and gonad primordium (g).Graham et al. Type IV Collagen Distribution in Caenorhabditis elegans 1177
tense stain of adjacent intestinal, gonadal, and body wall
muscle basement membranes.
It is notable that no emb-9 or let-2 reporter activity was
seen in pharyngeal, intestinal, or hypodermal cells of em-
bryos, larvae, or adults. This result is consistent with the
fact that anti–type IV collagen antisera did not show intra-
cellular stain in these tissues. However, it is surprising be-
cause the pharynx and intestine are covered by basement
membranes that do stain with the anti–type IV collagen
antisera. Although the pharyngeal and intestinal basement
membranes contain EMB-9 and LET-2, the genes encod-
ing them are not expressed in these tissues.
Type IV Collagen Expressed in Muscle Cells Can 
Assemble on Other Tissues
The strong expression of emb-9 and let-2 in body wall mus-
cle cells suggests that they could be the source of the type
IV collagen found in the pharyngeal and intestinal base-
ment membranes. To determine if type IV collagen pro-
duced in body wall muscle cells can assemble on other tis-
sues, we constructed an epitope-tagged emb-9 gene that is
transcriptionally controlled by the body wall muscle–spe-
cific unc-54 promoter and enhancer, pJJ414 (Fig. 1 A). The
unc-54 gene encodes the body wall muscle myosin heavy
chain MHC-B (33), and the specificity of its promoter has
been well documented (44). The epitope tag consists of two
tandem copies of the nine–amino acid HA peptide (67).
Transgenic lines carrying the construct were generated in
the wild-type N2 background and stained with anti-HA
and –type IV collagen antibodies.
In lima through 1 1/2-fold embryos, the anti-HA stain is
seen in body wall muscle cells (Fig. 7 A), coincident with
stain for the LET-2 chain (Fig. 7 D). In later embryos,
when wild-type type IV collagen is localized largely in
basement membranes (Fig. 7 E), the HA-tagged mole-
Figure 5. Type IV collagen distribution in wild-type C. elegans larvae and adults. Anti–LET-2 (A) and anti–UNC-54 myosin (B) stain of
a frozen section through the head of an adult animal. The Type IV stain is associated with the pharynx (p) and four body wall muscle
quadrants. There is not type IV collagen stain between muscle quadrants. Type IV collagen stain is localized near the myosin stain, which
is closely apposed to the hypodermal face of body wall muscle cells. (C) Anti–EMB-9 stain of an L2 larva showing localization to base-
ment membranes surrounding the pharynx (p), intestine (i), and gonad (g). (D) Anti–EMB-9 stain of an L4 larva showing reaction with
the gonad basement membrane (g) and with two coelomocytes (cc). (E) Anti–LET-2 stain of an adult showing intense stain surrounding
the spermatheca (sp).The Journal of Cell Biology, Volume 137, 1997 1178
cules are mostly still intracellular (Fig. 7 B). This intracel-
lular retention appears similar to that seen in animals with
mutations in either of the type IV collagen genes (20a). In
very late embryos that are close to hatching, weak HA
staining is detectable on the surface of the pharynx and in-
testine (Fig. 7, C and F). Thus, the epitope-tagged EMB-9
chain is expressed in body wall muscle as expected; how-
ever, the presence of the HA epitope tag at the carboxyl
end of EMB-9 appears to interfere with its proper assem-
bly and/or secretion.
The inhibition of HA-tagged EMB-9 secretion is not
complete, however, since in larvae and adults carrying
pJJ414, strong staining with anti-HA antibodies is seen
covering the pharynx and intestine (Fig. 7, G and H). This
staining is coincident with that seen with anti–type IV col-
lagen antisera (Fig. 7, I and J). Staining with HA antibod-
ies beneath body wall muscles and over the gonad can also
be detected. Animals in the same preparation that do not
carry the transgenic array show no staining, demonstrating
the specificity of the HA antibody (Fig. 7, G–J). These re-
sults show that type IV collagen produced in body wall
muscle cells can assemble into the basement membranes
covering other tissue.
Expression of EMB-9 in Body Wall Muscle Can Rescue 
emb-9 Mutant Animals
As a test of how much type IV collagen function can be
provided by expression in body wall muscle cells, we asked
how far animals could develop if they produced functional
Figure 6. Expression of type IV collagen genes in C. elegans. Expression reporters for emb-9 and let-2 show activity in the same cells and
at the same times. (A) A 1 1/2-fold embryo showing GFP activity from the emb-9 reporter pJJ446 in body wall muscle cells. (B) A two-
fold embryo showing b-galactosidase activity from pJJ318 in body wall muscle cells. (C) An L2 larva showing b-galactosidase activity from
pJJ318 in the distal tip cells (dtc) of the gonad. (D) An L1 larva showing b-galactosidase activity from pJJ444 in body wall muscle cells
and ring ganglion cells (rg). (E) A late L3 larva showing b-galactosidase activity from pJJ444 in the distal tip cells (dtc) of the gonad. (F)
A young adult animal showing b-galactosidase activity from pJJ318 in spermathecal cells (sp) and vulval muscles (vul). (G) A young
adult animal showing GFP activity from pJJ446 in body wall muscle cells. (H) An adult animal showing GFP activity from pJJ446 in a
distal tip cell (dtc) of the gonad.Graham et al. Type IV Collagen Distribution in Caenorhabditis elegans 1179
type IV collagen only in body wall muscle cells. The body
wall muscle-specific unc-54 promoter and enhancer were
placed immediately upstream of the initiation codon of the
complete wild-type emb-9 gene to create pJJ414 (Fig. 1 A).
This construct was used to generate transgenic arrays in ani-
mals carrying an emb-9 nonsense mutation linked to an Unc
marker maintained over a balancer chromosome, unc-36
(e251) emb-9(g23cg45)/qC1. Normally, this stain segregates
no Unc progeny because of the strict embryonic lethality
of the emb-9 nonsense mutation.
We expected that, at best, sterile adults could develop
from emb-9(g23cg45) animals carrying pJJ427, since the nor-
mal gonadal type IV collagen expression would be absent.
To our surprise, viable and fertile transgenic Unc animals
were generated by injecting the unc-54:emb-9 construct.
We have established several lines that are homozygous
unc-36(e251) emb-9(g23cg45) and are rescued by arrays
carrying the pJJ427 construct. The rescued animals grow
slowly; many arrest during larval development, and those
that reach adulthood have small brood sizes. However, the
strains can be maintained. These results indicate that ex-
pression of functional type IV collagen only in body wall
muscles is sufficient for C. elegans to develop to adulthood
and to reproduce.
It is possible that the presence of the complete emb-9
coding region in the pJJ427 construct could alter the ex-
pression pattern of the unc-54 promoter and enhancer. To
test this possibility, GFP was inserted into exon 10 of the
construct to create pJJ429 (Fig. 1 A). Transgenic animals
carrying pJJ429 show strong GFP activity only in body
wall muscle cells (Fig. 8 A). No activity was seen in the
pharynx, intestine, or gonad. Therefore, rescue of emb-9
(g23cg45) mutant animals is possible by expression of
functional  emb-9 solely in body wall muscle cells.
Embryos homozygous for emb-9(g23cg45) do not stain
with anti–EMB-9 antisera and show only intracellular
accumulation, no basement membrane stain, with anti–
LET-2 antisera (20a). We stained pJJ427-rescued emb-9
(g23cg45) embryos with anti–EMB-9 antisera and found
that EMB-9 is present in pharyngeal, intestinal, and go-
nadal basement membranes and under body wall muscles
(Fig. 8, B–D). This result further demonstrates that type
IV collagen produced in body wall muscle cells can assem-
ble into basement membranes covering other tissues, and
Figure 7. Distribution of HA-tagged EMB-9 expressed from the unc-54 body wall muscle myosin promoter construct pJJ414. Animals
were stained with anti-HA monoclonal antibody (A–C, G, and H), and with anti–LET-2 antiserum (D–F, I, and J). (A) In a 1 1/2-fold
embryo, anti-HA staining colocalizes in body wall muscle cells with LET-2 (D). (B) In a threefold embryo, the HA-tagged EMB-9 is re-
tained within the body wall muscle cells, while LET-2 is seen in basement membranes (E). (C) In a fourfold embryo, a small amount of
HA-tagged EMB-9 can be seen in the pharyngeal basement membrane, while LET-2 staining of basement membranes is intense (F). In
L2–L3 larvae, HA-tagged EMB-9 is seen in pharyngeal (p) and intestinal (i) basement membranes (G and H) and can also be detected
under body wall muscle quadrants and around the gonad. Animals that do not carry the transgenic array, and do not stain with anti-HA
antibody, are indicated with arrowheads. Staining of the same animals with anti–LET-2 (I and J) shows that the HA-tagged EMB-9 colo-
calizes with LET-2.The Journal of Cell Biology, Volume 137, 1997 1180
that it can do so in the absence of any other source of type
IV. It also shows that type IV collagen derived from body
wall muscles is sufficient for development of C. elegans to
the adult stage and for at least partial fertility.
Discussion
We have used specific antisera to localize the a1 and
a2(IV) collagen chains of C. elegans, EMB-9 and LET-2.
Type IV collagen was first detectable within body wall mus-
cle cells of C. elegans embryos just beginning morphogene-
sis. Consistent with this result, the temperature-sensitive
periods for both type IV collagen genes, emb-9 and let-2,
also begin at this time (23,40; Kramer, J., unpublished re-
sults). Soon after, at the comma stage, secreted type IV
collagen begins to form stripes under the body wall muscle
quadrants. At approximately the same time, type IV col-
lagen first appears around the primordial pharynx and in-
testine. By the end of embryogenesis, type IV collagen un-
derlies the body wall muscle cells and surrounds the
pharynx, intestine, and gonad primordium. The same gen-
eral pattern of type IV collagen localization continues in
larval and adult animals.
Antisera against EMB-9 and LET-2 give the same spa-
tial and temporal staining patterns in wild-type animals,
indicating that these chains are colocalized. Additionally,
in animals with missense mutations of either chain, the dis-
tributions of the chains are altered but still colocalized, and
in animals with nonsense mutations in emb-9, the LET-2
chain is retained intracellularly and not secreted (20a).
The colocalization of EMB-9 and LET-2 and the inability
of LET-2 to be secreted in the absence of EMB-9 indicates
that the two chains do not function independently. Since
EMB-9 and LET-2 are a1 and a2-like type IV collagen
chains, respectively (19), they may assemble into a single
heterotrimeric collagen molecule as do the vertebrate a1
and a2 chains. These results are consistent with the notion
that EMB-9 and LET-2 function in a single heterotrimeric
type IV collagen molecule.
Basement membranes in two regions of C. elegans did
not stain with anti–type IV collagen antisera at any stage,
those on the hypodermis between the body wall muscle
quadrants and those on the pseudocoelomic face of body
wall muscles (Fig. 3). The basement membranes in these
regions appear ultrastructurally similar to those that cover
the intestine and gonad (66) and do stain for type IV col-
lagen. There are three possible explanations for the failure
to detect type IV collagen in these regions of basement
membrane.
First, it is possible that EMB-9 and LET-2 are present
but their epitopes are masked in these regions. Acid-urea
extraction, which can uncover masked epitopes in verte-
brate basement membranes (69), of whole animals or fro-
zen sections of C. elegans had no effect on the type IV col-
lagen staining pattern. All four type IV antisera fail to
stain these regions in animals that are fixed with parafor-
maldehyde or methanol/acetone and in frozen sections.
These  results make the possibility of epitope masking un-
likely and support the idea that EMB-9 and LET-2 are ab-
sent from these regions.
Second, it is possible that there is type IV collagen
present that is produced by an unidentified gene(s). South-
ern blot analyses indicated that emb-9 and let-2 are likely
to be the only type IV collagen gene in C. elegans (19). At
Figure 8. Transgenic rescue
of emb-9(g23cg45) embryos
with an unc-54 promoter:
emb-9 construct. (A) An L2
larva carrying the unc-54:
emb-9:GFP reporter pJJ429.
The GFP activity is seen only
in body wall muscle cells.
Muscle arm projections to
the nerve ring are indicated
(ma). (B–D) Homozygous
emb-9(g23cg45) embryos
carrying the unc-54 pro-
moter:emb-9 construct pJJ427
show anti–EMB-9 staining of
basement membranes cover-
ing the pharynx (p), intestine
(i), and gonad and under
body wall muscle quadrants
(bwm). In the absence of the
rescuing construct, embryos
that are homozygous for the
putative null mutation emb-
9(g23cg45) show no staining
with anti–EMB-9 antisera.Graham et al. Type IV Collagen Distribution in Caenorhabditis elegans 1181
this time, with approximately one-half of the C. elegans ge-
nome sequence complete (61), no other type IV collagen
genes have been identified. Multiple cDNA clones derived
from emb-9 and let-2 have been identified by C. elegans
EST database projects (62; Kohara, Y., personal commu-
nication), but no other type IV collagen transcripts have
been seen. Although it is not yet possible to exclude the
existence of another type IV collagen gene(s) in C. elegans,
the probability is small.
Finally, it is possible that there is no type IV collagen in
these regions of basement membrane. Although basement
membranes can vary in the collagen isoforms they contain
(37, 48), they all appear to contain some type IV collagen.
There is evidence that during angiogenesis, newly forming
basement membranes are laminin rich and lack type IV
collagen (15), and there are cell lines that secrete matrix lack-
ing type IV collagen (5, 16). However, there are no reports
of fully formed in vivo basement membranes that do not
contain type IV collagen. The regions in C. elegans on the
surface of the hypodermis between body wall muscle quad-
rants and on the pseudocoelomic face of body wall muscle
cells may be basement membrane–like structures that lack
type IV collagen.
Whichever of the above possibilities is true, it is clear
that the composition and/or modifications of the basement
membranes between body wall muscle quadrants and on
the pseudocoelomic face of muscles must be different
from the other basement membranes in C. elegans. An-
other basement membrane component, the UNC-52 perle-
can homologue of C. elegans, is also not detected in these
same regions of basement membrane (42).
We have identified the cells that express the emb-9 and
let-2 type IV collagen genes using reporter constructs in
transgenic animals. With minor exception, the type IV col-
lagen–expressing cells in C. elegans are mesodermal. The
mesoderm of C. elegans is derived from four founder cells,
MS, D, Cap, and Cpp (54, 55). The D, Cap, and Cpp
founders generate only body wall muscle cells, all of which
express type IV collagen. The MS cell generates body wall
muscles and several other type IV collagen–expressing cell
types (Fig. 9). Notably, all of the embryonic MS-derived
cells express type IV collagen, except the pharyngeal cells.
Type IV collagen expression is also confined to mesoder-
mal cells in Drosophila (25, 32, 39) and sea urchin (9, 63).
In vertebrates, type IV collagen expression has been re-
ported in both mesenchymal and epithelial cells of several
tissues (34, 49, 57, 58), although it is restricted to the mes-
enchyme in mouse intestine (52).
The combination of antibody localization and gene re-
porter results indicated that the pharynx and intestine do
not express the a1 or a2(IV) genes, emb-9 or let-2, even
though these tissues are covered by basement membranes
that contain their products. Also, type IV collagen antisera
stain the entire surface of the gonadal basement mem-
brane, even though only a few cells located at the distal
and proximal ends of the gonad express the type IV col-
lagen genes. We demonstrated that a1(IV) chains synthe-
sized in body wall muscle can assemble into basement
membranes on these other tissues. Additionally, we found
that expression of functional type IV collagen only in body
wall muscles is sufficient for C. elegans to complete devel-
opment and be at least partially fertile.
These results raise the question of how the sites of type
IV collagen assembly into basement membranes are deter-
mined. Presumably, body wall muscle cells secrete type IV
collagen from both their hypodermal and pseudocoelomic
Figure 9. Diagram of the em-
bryonic MS blastomere lin-
eage showing type IV col-
lagen–expressing cells. Cells
that express type IV col-
lagen are shown as filled cir-
cles. Cells that divide during
larval development (M, Z1,
Z4) are circled at the bottom
of the figure, and their prog-
eny that express type IV col-
lagen are indicated. Cell fates
are indicated as: bm, body
wall muscle; cc, coelomocyte;
dtc, distal tip cell; hm, head
mesodermal cell; im, intesti-
nal muscle; ph, pharynx; rg,
ring ganglion; sp, sperma-
theca;  um, uterine muscle; vm,
vulval muscle. Several body
wall muscle cells derived from
the C and D blastomeres and
one body wall, one intestinal,
and two anal muscles derived
from the AB blastomere also
express type IV collagen. The
lineage was modified from
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faces. Body wall muscle cells are closely apposed to the hy-
podermis, and collagen secreted into the small intervening
space could assemble into the stripes seen beneath the
body wall muscle quadrants. The type IV collagen that
assembles into the pharyngeal, intestinal, and gonadal
basement membranes is likely to be secreted from the
pseudocoelomic face of the muscle cells. Notably, the base-
ment membranes that cover the pseudocoelomic face of
body wall muscle cells do not contain detectable type IV
collagen. Since the body wall muscle quadrants extend
from the head to the tail of the animal, secretion into and
diffusion within the pseudocoelomic cavity could provide
the necessary type IV collagen for all other tissues.
The remaining question is why all basement membranes
that are exposed to the pseudocoelomic cavity do not con-
tain type IV collagen? As noted above, type IV collagen is
not detectable in the basement membranes on the pseudo-
coelomic face of muscle cells or on the hypodermis be-
tween body and wall muscle quadrants. Either something
is present in these regions that blocks type IV collagen as-
sembly, or something that is required to promote assembly
is absent from these regions. We favor the latter possibil-
ity, since assembly could be promoted by simply increasing
the local concentration of type IV collagen, while no inhib-
itors of assembly are known.
Type IV collagen can assemble into a polygonal lattice
in vitro in a concentration-dependent manner (70). How-
ever, the in vivo concentration of type IV collagen may be
too low to allow such unassisted assembly. Higher local
concentrations of type IV collagen could be achieved if it
bound to cell surface receptors or other cell-associated
basement membrane components. Likely candidates for
this function are integrins and/or nidogen, both of which
have been identified in C. elegans (18; Kramer, J., unpub-
lished results). Binding to these molecules could produce
local concentrations of type IV collagen high enough for
assembly to occur. Thus, the localization of type IV col-
lagen may be determined by the localization of cell-associ-
ated molecules to which it binds.
The sources and final locations of type IV collagen have
been determined in some vertebrate systems. In cocultures
of mouse epithelium with chick endothelium, the develop-
ing kidney glomerular basement membrane was shown to
have type IV collagen contributed by both species (49). In
cocultures of fetal intestinal chick mesenchyme with rat en-
doderm, the resulting subepithelial basement membrane
was found to have type IV collagen derived only from the
mesenchyme (52, 53). In cocultures of bovine keratino-
cytes and human fibroblasts, both cell types contributed
type IV collagen to the dermal–epidermal basement mem-
brane (34), while nidogen was derived only from fibro-
blasts (14). So, the type IV collagen in a basement mem-
brane can be derived from cells on either or both sides of
it. In these cases, the two groups of cells contributing to
basement membrane formation are generally present
along a continuous interface. In C. elegans, the situation is
different because the body wall muscle cells that produce
type IV collagen are not immediately adjacent to all sites
at which it assembles (Fig. 3). However, the localized as-
sembly of type IV collagen in both the vertebrate and C.
elegans studies suggest that it must interact with other
molecules to direct its assembly.
The assembly properties of the perlecan homologue of
C. elegans, UNC-52, are different from those of type IV
collagen. UNC-52 is deposited in the basement membrane
close to its sites of synthesis (42). The tissues that have
UNC-52 in their basement membranes all express the unc-52
gene. Laser ablation of body wall muscle cells results in a
hole in the UNC-52 antibody staining pattern where the
cells are missing, indicating that UNC-52 does not move
far from its site of synthesis. In C. elegans, two basement
membrane components assemble in different ways; perle-
can is deposited locally, while type IV collagen can assem-
ble at sites distant from its site of synthesis.
We wish to thank David Miller (Vanderbilt University, Nashville, TN) for
providing antibodies and Andrew Fire (Carnegie Institute, Baltimore,
MD) for providing expression vectors.
This work was supported by National Institutes of Health grant
HD22027 (J.M. Kramer) and NRSA GM15268 (P.L. Graham).
Received for publication 17 February 1997 and in revised form 22 March
1997.
References
1. Albertson, D.G., and J.N. Thomson. 1976. The pharynx of Caenorhabditis
elegans. Philos. Trans. R. Soc. London Ser. B. Biol. Sci. 275:299–325.
2. Antignac, C. 1995. Molecular genetics of basement membranes: the para-
digm of Alport syndrome. Kidney Int. 47:S29–S33.
3. Blumberg, B., A.J. MacKrell, P.F. Olson, M. Kurkinen, J.M. Monson, J.E.
Natzle, and J.H. Fessler. 1987. Basement membrane procollagen IV and
its specialized carboxyl domain are conserved in Drosophila, mouse and
human. J. Biol. Chem. 262:5947–5950.
4. Blumberg, B., A.J. MacKrell, and J.H. Fessler. 1988. Drosophila basement
membrane procollagen a1(IV) II. Complete cDNA sequence, genomic
structure, and general implications for supramolecular assemblies. J.
Biol. Chem. 263:18328–18337.
5. Brauer, P.R., and J.M. Keller. 1989. Ultrastructure of a model basement
membrane lacking type IV collagen. Anat. Rec. 223:376–383.
6. Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics. 77:71–94.
7. Caulagi, V.R., and T.V. Rajan. 1995. The structural organization of an a2
(type IV) basement membrane collagen gene from the filarial nematode
Brugia malayi. Mol. Biochem. Parasitol. 70:227–229.
8. Cosgrove, D., D.T. Meehan, J.A. Grunkemeyer, J.M. Kornak, R. Sayers,
W.J. Hunter, and G.C. Samuelson. 1996. Collagen COl4A3 knockout: a
mouse model for autosomal Alport syndrome. Genes Dev. 10:2981–2992.
9. Exposito, J.Y., M. Dalessio, M. Diliberto, and F. Ramirez. 1993. Complete
primary structure of a sea urchin type-IV collagen-a chain and analysis of
the 59 end of its gene. J. Biol. Chem. 268:5249–5254.
10. Exposito, J.Y., H. Suzuki, C. Geourjon, R. Garrone, M. Solursh, and F.
Ramirez. 1994. Identification of a cell lineage-specific gene coding for a
sea urchin a2(IV)-like collagen chain. J. Biol. Chem. 269:13167–13171.
11. Finney, M., and G.B. Ruvkun. 1990. The unc-86 gene product couples cell
lineage and cell identity in C. elegans. Cell. 63:895–905.
12. Fire, A. 1992. Histochemical techniques for locating Escherichia coli b-galac-
tosidase activity in transgenic organism. Genet. Anal. Tech. Appl. 9:151–158.
13. Fire, A., S.W. Harrison, and D.K. Dixon. 1990. A modular set of lacZ fu-
sion vectors for studying gene expression in Caenorhabditis elegans.
Gene. 93:189–198.
14. Fleischmajer, R., A. Schechter, M. Bruns, J.S. Perlish, E.D. Macdonald,
T.C. Pan, R. Timpl, and M.L. Chu. 1995. Skin fibroblasts are the only
source of nidogen during early basal lamina formation in vitro. J. Invest.
Dermatol. 105:597–601.
15. Form, D.M., B.M. Pratt, and J.A. Madri. 1986. Endothelial cell prolifera-
tion during angiogenesis. Lab. Invest. 55:521–530.
16. Frenette, G.P., R.W. Ruddon, R.F. Krzesicki, J.A. Naser, and B.P. Peters.
1989. Biosynthesis and deposition of a noncovalent laminin-heparan sul-
fate proteoglycan complex and other basal lamina components by a hu-
man malignant cell line. J. Biol. Chem. 264:3078–3088.
17. Freytag, J.W., M.E. Noelken, and B.G. Hudson. 1979. Physical properties
of collagen-sodium dodecyl sulfate complexes. Biochemistry. 18:4761–
4768.
18. Gettner, S.N., C. Kenyon, and L.F. Reichardt. 1995. Characterization of
bpat-3 heterodimers, a family of essential integrin receptors in C. elegans.
J. Cell Biol. 129:1127–1141.
19. Guo, X., and J.M. Kramer. 1989. The two Caenorhabditis elegans basement
membrane (type IV) collagen genes are located on separate chromo-
somes.  J. Biol. Chem. 264:17575–17582.
20. Guo, X., J.J Johnson, and J.M. Kramer. 1991. Embryonic lethality caused
by mutations in basement membrane collagen of C. elegans. NatureGraham et al. Type IV Collagen Distribution in Caenorhabditis elegans 1183
(Lond.). 349:707–709.
20a. Gupta, M., P.L. Graham, and J.M. Kramer. 1997. Characterization of
a1(IV) collagen mutations in Caenorhabditis elegans and the effects of a1
and a2(IV) mutations on type IV collagen distribution. J. Cell Biol. 137:
1185–1196.
21. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 726 pp.
22. Hudson, B.G., S.T. Reeders, and K. Tryggvason. 1993. Type IV collagen:
structure, gene organization, and role in human diseases. Molecular basis
of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J.
Biol. Chem. 268:26033–26036.
23. Isnenghi, E., K. Cassada, C. Smith, K. Denitch, A. Radnia, and G. von Eh-
renstein. 1983. Maternal effects and temperature-sensitive period of mu-
tations affecting embryogenesis in Caenorhabditis elegans. Dev. Biol. 98:
465–480.
24. Kashtan, C.E., and Y. Kim. 1992. Distribution of the a1 and a2 chains of
collagen IV and of collagens V and VI in Alport syndrome. Kidney Int.
42:115–126.
25. Knibiehler, B., C. Mirre, J.P. Cecchini, and Y. Le Parco. 1987. Haemocytes
accumulate collagen transcripts during Drosophila melanogaster meta-
morphosis. Roux’s Arch. Dev. Biol. 196:243–247.
26. Kramer, J.M. 1994. Genetic analysis of extracellular matrix in C. elegans.
Annu. Rev. Genet. 28:95–116.
27. Kramer, J.M. 1994. Structures and functions of collagens in Caenorhabditis
elegans. FASEB (Fed. Am. Soc. Exp. Biol.) J. 8:329–336.
28. Kramer, J.M., and J.J. Johnson. 1993. Analysis of mutations in the sqt-1 and
rol-6 collagen genes of Caenorhabditis elegans. Genetics. 135:1035–1045.
29. Kuhn, K. 1994. Basement membrane (type IV) collagen. Matrix Biol. 14:
439–445.
30. Laemmli, U.K. 1970. Cleavage of structural proteins during assembly of the
head of bacteriophage T4. Nature (Lond.). 227:680–685.
31. Lemmink, H.H., T. Mochizuki, L.P.W.J. Vandenheuvel, C.H. Schroder, A.
Barrientos, L.A.H. Monnens, B.A. Vanoost, H.G. Brunner, S.T. Reed-
ers, and H.J.M. Smeets. 1994. Mutations in the type IV collagen a3
(COL4A3) gene in autosomal recessive Alport syndrom. Hum. Mol.
Genet.  3:1269–1273.
32. Lunstrum, G.P., H.-P. Bachinger, L.I. Fessler, K.G. Duncan, R.E. Nelson,
and J.H. Fessler. 1988. Drosophila basement membrane procollagen IV:
I. Protein characterization and distribution. J. Biol. Chem. 263:18318–
18327.
33. MacLeod, A.R., R.H. Waterston, R.M. Fishpool, and S. Brenner. 1977.
Identification of the structural gene for a myosin heavy chain in Cae-
norhabditis elegans. J. Mol. Biol. 114:133–140.
34. Marinkovich, M.P., D.R. Keene, C.S. Rimberg, and R.E. Burgeson. 1993.
Cellular origin of the dermal-epidermal basement membrane. Dev. Dyn.
197:255–267.
35. Mello, C., and A. Fire. 1995. DNA transformation. In Methods in Cell Biol-
ogy. Vol. 48. H.F. Epstein and D.C. Shakes, editors. Academic Press Inc.,
San Diego. 451–482.
36. Mello, C.C., J.M. Kramer, D. Stinchcomb, and V. Ambros. 1991. Efficient
gene transfer in C. elegans: extrachromosomal maintenance and integra-
tion of transforming sequences. EMBO (Eur. Mol. Biol. Organ.) J. 10:
3959–3970.
37. Miner, J.H., and J.R. Sanes. 1994. Collagen IV a3, a4, and a5 chains in ro-
dent basal laminae: sequence, distribution, association with laminins, and
developmental switches. J. Cell Biol. 127:879–891.
38. Miner, J.H., and J.R. Sanes. 1996. Molecular and functional defects in kid-
neys of mice lacking collagen a3(IV): implications for Alport syndrome.
J. Cell Biol. 135:1403–1413.
39. Mirre, C., J.P. Cecchini, Y. Le Parco, and B. Knibiehler. 1988. De novo ex-
pression of a type IV collagen gene in Drosophila embryos is restricted to
mesodermal derivatives and occurs at germ band shortening. Develop-
ment (Camb.). 102:369–376.
40. Miwa, J., E. Schierenberg, S. Miwa, and G. von Ehrenstein. 1980. Genetics
and mode of expression of temperature-sensitive mutations arresting em-
bryonic development in Caenorhabditis elegans. Dev. Biol. 76:160–174.
41. Mochizuki, T., H.H. Lemmink, M. Mariyama, C. Antignac, M.C. Gubler,
Y. Pirson, C. Verellendumoulin, B. Chan, C.H. Schroder, H.J. Smeets,
and S.T. Reeders. 1994. Identification of mutations in the a3(IV) and
a4(IV) collagen genes in autosomal recessive Alport syndrome. Nat.
Genet. 8:77–82.
42. Moerman, D.G., H. Hutter, G.P. Mullen, and R. Schnabel. 1996. Cell au-
tonomous expression of perlecan and plasticity of cell shape in embry-
onic muscle of Caenorhabditis elegans. Dev. Biol. 173:228–242.
43. Ninomiya, Y., M. Kagawa, K. Iyama, I. Naito, Y. Kishiro, J.M. Seyer, M.
Sugimoto, T. Oohashi, and Y. Sado. 1995. Differential expression of two
basement membrane collagen genes, COL4A6 and COL4A5, demon-
strated by immunofluorescence staining using peptide-specific mono-
clonal antibodies. J. Cell Biol. 130:1219–1229.
44. Okkema, P.G., S.W. Harrison, V. Plunger, A. Aryana, and A. Fire. 1993.
Sequence requirements for myosin gene expression and regulation in
Caenorhabditis elegans. Genetics. 135:385–404.
45. Peissel, B., L. Geng, R. Kalluri, C. Kashtan, H.G. Rennke, G.R. Gallo, K.
Yoshioka, M.J. Sun, B.G. Hudson, E.G. Neilson, and J. Zhou. 1995.
Comparative distribution of the a1(IV), a5(IV), and a6(IV) collagen chains
in normal human adult and fetal tissues and in kidneys from X-linked
Alport syndrome patients. J. Clin. Invest. 96:1948–1957.
46. Pettitt, J., and I.B. Kingston. 1991. The complete primary structure of a
nematode a2(IV) collagen and the partial structural organization of its
gene. J. Biol. Chem. 266:16149–16156.
47. Pettitt, J., and I.B. Kingston. 1994. Developmentally regulated alternative
splicing of a nematode type IV collagen gene. Dev. Biol. 161:22–29.
48. Sanes, J.R., E. Engvall, R. Butkowski, and D.D. Hunter. 1990. Molecular
heterogeneity of basal laminae: isoforms of laminin and collagen IV at
the neuromuscular junction and elsewhere. J. Cell Biol. 111:1685–1699.
49. Sariola, H., R. Timpl, K. von der Mark, R. Mayne, J.M. Fitch, T.F. Linsen-
mayer, and P. Ekblom. 1984. Dual origin of glomerular basement mem-
brane. Dev. Biol. 101:86–96.
50. Sibley, M.H., J.J. Johnson, C.C. Mello, and J.M. Kramer. 1993. Genetic
identification, sequence, and alternative splicing of the Caenorhabditis el-
egans a2(IV) collagen gene. J. Cell Biol. 123:255–264.
51. Sibley, M.H., P.L. Graham, N. von Mende, and J.M. Kramer. 1994. Muta-
tions in the a2(IV) basement membrane collagen gene of Caenorhabditis
elegans produce phenotypes of differing severities. EMBO (Eur. Mol.
Biol. Organ.). J. 13:3278–3285.
52. Simon-Assmann, P., F. Bouziges, J.N. Freund, F. Perrin-Schmitt, and M.
Kedinger. 1990. Type IV collagen mRNA accumulates in the mesenchy-
mal compartment at early stages of murine developing intestine. J. Cell
Biol. 110:849–857.
53. Simon-Assmann, P., M. Kedinger, A. De Arcangelis, V. Rousseau, and P.
Simo. 1995. Extracellular matrix components in intestinal development.
Experientia (Basel). 51:883–890.
54. Sulston, J.E., and H.R. Horvitz. 1977. Post-embryonic cell lineages of the
nematode, Caenorhabditis elegans. Dev. Biol. 56:110–156.
55. Sulston, J.E., E. Schierenberg, J.G. White, and J.N. Thomson. 1983. The
embryonic cell lineage of the nematode Caenorhabditis elegans. Dev.
Biol. 100:64–119.
56. Tabara, H., T. Motohashi, and Y. Kohara. 1996. A multi-well version of in
situ hybridization on whole mount embryos of Caenorhabditis elegans.
Nucleic Acids Res. 24:2119–2124.
57. Thomas, T., and M. Dziadek. 1993. Genes coding for basement membrane
glycoproteins laminin, nidogen, and collagen IV are differentially ex-
pressed in the nervous system and by epithelial, endothelial, and mesen-
chymal cells of the mouse embryo. Exp. Cell Res. 208:54–67.
58. Thomas, T., and M. Dziadek. 1994. Expression of collagen a1(IV), laminin
and nidogen genes in the embryonic mouse lung—implications for
branching morphogenesis. Mech. Dev. 45:193–201.
59. Timpl, R. 1989. Structure and activity of basement membrane proteins.
Eur. J. Biochem. 180:487–502.
60. Tryggvason, K. 1995. Molecular properties and diseases of collagens. Kid-
ney Int. 47:S24–S28.
61. Waterson, R., and J. Sulston. 1995. The genome of Caenorhabditis elegans.
Proc. Natl. Acad. Sci. USA. 92:10836–10840.
62. Waterson, R., C. Martin, M. Craxton, C. Huynh, A. Coulson, L. Hillier, R.
Durbin, P. Green, R. Shownkeen, N. Halloran, et al. 1992. A survey of
expressed genes in Caenorhabditis elegans. Nat. Genet. 1:114–123.
63. Wessel, G.M., M. Etkin, and S. Benson. 1991. Primary mesenchyme cells of
the sea urchin embryo require an autonomously produced, nonfibrillar
collagen for spiculogenesis. Dev. Biol. 148:261–272.
64. White, J. 1988. The anatomy. In the Nematode Caenorhabditis elegans.
W.B. Wood, editor. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY. 81–122.
65. White, J.G., E. Southgate, J.N. Thomson, and S. Brenner. 1976. The struc-
ture of the ventral nerve cord of Caenorhabditis elegans. Philos. Trans. R.
Soc. London Ser. B. Biol. Sci. 275:327–348.
66. White, J.G., E. Southgate, J.N. Thomson, and S. Brenner. 1986. The struc-
ture of the nervous system of Caenorhabditis elegans. Philos. Trans. R.
Soc. London Ser. B. Biol. Sci. 314:1–340.
67. Wilson, I.A., H.L. Niman, R.A. Houghten, A.R. Cherenson, M.L. Con-
nolly, and R.A. Lerner. 1984. The structure of an antigenic determinant
in a protein. Cell. 37:767–778.
68. Yoshioka, K., S. Hino, T. Takemura, S. Maki, J. Wieslander, Y. Takekoshi,
H. Makino, M. Kagawa, Y. Sado, and C.E. Kashtan. 1994. Type IV collagen
a5 chain—normal distribution and abnormalities in X-linked Alport syn-
drome revealed by monoclonal antibody. Am. J. Pathol. 144:986–996.
69. Yoshioka, K., A.F. Michael, J. Velosa, and A.J. Fish. 1985. Detection of
hidden nephritogenic antigen determinants in human renal and non-
renal basement membranes. Am. J. Pathol. 121:156–165.
70. Yurchenco, P.D., and H. Furthmayr. 1984. Assembly of basement mem-
brane collagen. Biochemistry. 23:1839–1850.
71. Yurchenco, P.D., and G.C. Ruben. 1987. Basement membrane structure in
situ: evidence for lateral associations in the type IV collagen network. J.
Cell Biol. 105:2559–2568.
72. Yurchenco, P.D., and J.C. Schittny. 1990. Molecular architecture of base-
ment membranes. FASEB (Fed. Am. Soc. Exp. Biol.) J. 4:1577–1590.
73. Zheng, K.Q., P.S. Thorner, P. Marrano, R. Baumal, and R.R. McInnes.
1994. Canine X chromosome-linked hereditary nephritis—a genetic
model for human X-linked hereditary nephritis resulting from a single
base mutation in the gene encoding the a5 chain of collagen type IV.
Proc. Natl. Acad. Sci. USA. 91:3989–3993.